Header
 
Login
 

Privatsphäre-Einstellungen

Wir verwenden Cookies auf unserer Website. Einige von ihnen sind unerlässlich, während andere uns helfen, diese Website und Ihre Erfahrungen zu verbessern.

Notwendig Statistik Marketing
Auswahl bestätigen
Weitere Einstellungen

Hier finden Sie eine Übersicht aller verwendeten Cookies. Sie können ganzen Kategorien Ihre Zustimmung geben oder weitere Informationen anzeigen und bestimmte Cookies auswählen.

Alle auswählen
Auswahl bestätigen
Notwendig Cookies
Wesentliche Cookies ermöglichen grundlegende Funktionen und sind für die ordnungsgemäße Funktion der Website erforderlich.
Statistik Cookies
Statistik-Cookies sammeln anonym Informationen. Diese Informationen helfen uns zu verstehen, wie unsere Besucher unsere Website nutzen.
Marketing Cookies
Marketing-Cookies werden von Werbekunden oder Publishern von Drittanbietern verwendet, um personalisierte Anzeigen zu schalten. Sie tun dies, indem sie Besucher über Websites hinweg verfolgen
Zurück

    Influence of Acrylic Resins and Ethylcellulose on Sustainment of Indometacin via Solid Dispersions

    Yassein El-said Hamza, Soad Yehia Amin, and Ahmed H. El-Shafey

    Pharmaceutics Department, Faculty of Pharmacy, Cairo University, Cairo (Egypt)

    Solid dispersions of indometacin in different release-retarding materials were prepared using acrylic resins (Eudragitâ RSPM, RLPM, E30D) and ethylcellulose 100 in different ratios, adopting the co-precipitation method, then compressed into tablets. Physical parameters and release rates were evaluated. The effects of various release retardants on anti-inflammatory characteristics and ulcerogenicity of indometacin were studied with the most appropriate preparation reached. Kollidon K-25 and hydroxypropylmethylcellulose (HPMC) were used as channeling agents to improve drug release. It was found that increasing contents of Eudragit RSPM were associated with a concomitant decrease of the drug release rate. The co-precipitate prepared with 20 % w/w Eudragit RSPM showed the highest retardation in the release profile and, hence, the incorporation of 10 % Kollidon K-25 modified the release profile. On the other hand, the release rate profile of indometacin from tabletted Eudragit RLPM co-precipitates showed a progressive decrease accompanying the increase of the Eudragit RLPM proportion in the co-precipitate. It was concluded that 1 and 2 % of Eudragit E30D retarded the drug release excess-ively over 8 h. However, a co-precipitate prepared with 0.5 % Eudragit E30D showed a remarkable drug release profile. Ethylcellulose 100 in ratios of 5, 10 and 20 % showed various extents of prolongation in drug release from tabletted co-precipitates. Incorporation of either 10 % Kollidon K-25 or 10 % hydroxy-propylmethylcellulose with the co-precipitate prepared with 20 % ethylcellulose 100 showed a marked improvement of the release rate. Tablets containing the co-precipitate of indometacin and 20 % Eudragit RSPM with 10 % Kollidon K-25 showed maximum anti-inflammatory activity with the least ulcer index compared to commercial indometacin capsules.

    Key words Acrylic resins · Ethylcellulose · Eudragitâ · Hydroxypropylmethylcellulose · Indometacin · Kollidon K-25 · Solid dispersions · Sustained release tablets

     




    © ECV- Editio Cantor Verlag (Germany) 2000

     

    pharmind 2000, Nr. 7, Seite 551